An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

Nearly three-quarters of U.S. adults (72%) say the COVID-19 pandemic did more to drive the country apart than to bring it ...

Each year, flu experts from around the world gather to map out recommendations for next winter's flu vaccine. This year, it's ...

Kennedy has expressed support for some fields, but has also declared he’d like a ‘break’ in infectious-disease research.

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

Robert F. Kennedy Jr. cited a disputed study from a close network of fellow vaccine skeptics during his confirmation hearings ...

Scientists at Sanaria and Seattle Children's Research Institute's Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, ...

After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...

Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria® PfSPZ-LARC2 Vaccine, ...

RFK Jr.’s views on vaccine safety have sparked debate, with some experts saying that his comments are misleading.